Marshall Wace
ELAN icon

Marshall Wace’s Elanco Animal Health ELAN Stock Holding History

Marshall Wace’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109M Buy
4,432,350
+3,049,938
+221% +$70.5M 0.09% 183
2026
Q1 		$33.1M Buy
+1,382,412
New +$33.8M 0.03% 512
2025
Q4 		– Sell
-367,344
Closed -$7.4M – 3085
2025
Q3 		$7.4M Buy
367,344
+12,078
+3% +$202K 0.01% 1034
2025
Q2 		$5.07M Sell
355,266
-154,315
-30% -$1.8M 0.01% 1131
2025
Q1 		$5.35M Buy
509,581
+341,758
+204% +$3.87M 0.01% 1029
2024
Q4 		$2.03M Sell
167,823
-230,676
-58% -$3.02M ﹤0.01% 1422
2024
Q3 		$5.85M Sell
398,499
-986,616
-71% -$13.7M 0.01% 935
2024
Q2 		$20M Sell
1,385,115
-5,497,626
-80% -$87.8M 0.03% 500
2024
Q1 		$112M Buy
6,882,741
+5,304,997
+336% +$82.9M 0.17% 110
2023
Q4 		$23.5M Buy
1,577,744
+1,274,406
+420% +$14.4M 0.04% 430
2023
Q3 		$3.41M Sell
303,338
-2,793,029
-90% -$32.4M 0.01% 1008
2023
Q2 		$31.1M Buy
3,096,367
+2,158,367
+230% +$20M 0.06% 332
2023
Q1 		$8.82M Buy
938,000
+53,221
+6% +$628K 0.02% 756
2022
Q4 		$10.8M Buy
884,779
+254,983
+40% +$3.18M 0.02% 749
2022
Q3 		$7.82M Buy
629,796
+297,263
+89% +$5.2M 0.02% 1072
2022
Q2 		$6.53M Buy
332,533
+267,098
+408% +$6.32M 0.01% 1157
2022
Q1 		$1.71M Buy
+65,435
New +$1.74M ﹤0.01% 2153
2021
Q3 		– Sell
-522,823
Closed -$18.1M – 3116
2021
Q2 		$18.1M Buy
522,823
+418,272
+400% +$13.8M 0.08% 260
2021
Q1 		$3.08M Buy
104,551
+61,553
+143% +$1.89M 0.01% 1098
2020
Q4 		$1.32M Buy
+42,998
New +$1.31M 0.01% 1100
2020
Q3 		– Sell
-160,979
Closed -$3.45M – 1659
2020
Q2 		$3.45M Buy
+160,979
New +$3.56M 0.02% 596
2020
Q1 		– Sell
-1,055,573
Closed -$31.1M – 1729
2019
Q4 		$31.1M Buy
1,055,573
+464,858
+79% +$12.6M 0.21% 112
2019
Q3 		$15.7M Buy
590,715
+327,440
+124% +$9.82M 0.12% 195
2019
Q2 		$8.9M Buy
+263,275
New +$8.55M 0.07% 317

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Marshall Wace's ELAN Position: Q2 2026 in Review

Marshall Wace increased its Elanco Animal Health (ELAN) stake by 221% in Q2 2026, buying an estimated $70.5M and bringing the position to 4,432,350 shares worth $109M. The position accounts for 0.09% of the portfolio, ranked #183.

Marshall Wace first reported a position in ELAN in Q2 2019 and has held it in 24 quarters since. The position peaked at $112M in Q1 2024. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Marshall Wace held 4,432,350 shares of Elanco Animal Health worth $109M as of Q2 2026.
  • Marshall Wace bought 3,049,938 Elanco Animal Health shares in Q2 2026, an estimated $70.5M.
  • Elanco Animal Health made up 0.09% of Marshall Wace's portfolio in Q2 2026, its #183 holding.
  • Marshall Wace first reported a position in Elanco Animal Health in Q2 2019 and has held it in 24 quarters since.
  • Marshall Wace's Elanco Animal Health position peaked at $112M in Q1 2024.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.